Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists

5-Fluoro-2-methyl-<i>N</i>-[4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>]- [1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985):  An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors

J. Donald Albright, Marvin F. Reich, Efren G. Delos Santos et al. · Journal of Medicinal Chemistry · 1998 · 149 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Preparation of some dibenz[b,f][1,4]oxazepines and dibenz[b,e]azepines

Arthur W. H. Wardrop, Gordon L. Sainsbury, J. M. Harrison et al. · Journal of the Chemical Society Perkin Transactions 1 · 1976 · 49 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

Recent Advances in the Discovery and Development of Vasopressin Antagonists: Peptide and Nonpeptide Vta and V2 Receptor Antagonists

J. Donald Albright, Peter S. Chan · Current Pharmaceutical Design · 1997 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +17

The synthesis and vasopressin (AVP) antagonist activity of a novel series of n-aroyl-2,4,5,6-tetrahydropyrazolo [3,4-d]thieno[3,2-b]azepines

J. Donald Albright, Efren G. Delos Santos, John P. Dusza et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Derivatives of 11-(1-piperazinyl)-5H-pyrrolo[2,1-c][1,4]benzodiazepine as central nervous system agents

William B. Wright, Eugene N. Greenblatt, Ivana P. Day et al. · Journal of Medicinal Chemistry · 1980 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +7